Asymmetric hydrogenation catalyst nature

Efficient enantioselective asymmetric hydrogenation of prochiral ketones and olefins has been accompHshed under mild reaction conditions at low (0.01— 0.001 mol %) catalyst concentrations using rhodium catalysts containing chiral ligands (140,141). Practical synthesis of several optically active natural... 

Catalytic asymmetric hydrogenation is a relatively developed process compared to other asymmetric processes practised today. Efforts in this direction have already been made. The first report in this respect is the use of Pd on natural silk for hydrogenating oximes and oxazolones with optical yields of about 36%. Izumi and Sachtler have shown that a Ni catalyst modified with (i ,.R)-tartaric acid can be used for the hydrogenation of methylacetoacetate to methyl-3-hydroxybutyrate. The group of Orito in Japan (1979) and Blaser and co-workers at Ciba-Geigy (1988) have reported the use of a cinchona alkaloid modified Pt/AlaO.i catalyst for the enantioselective hydrogenation of a-keto-esters such as methylpyruvate and ethylpyruvate to optically active (/f)-methylacetate and (7 )-ethylacetate. 

Another hypothesis on homochirality involves interaction of biomolecules with minerals, either at rock surfaces or at the sea bottom thus, adsorption processes of biomolecules at chiral mineral surfaces have been studied. Klabunovskii and Thiemann (2000) used a large selection of analytical data, provided by other authors, to study whether natural, optically active quartz could have played a role in the emergence of optical activity on the primeval Earth. Some researchers consider it possible that enantioselective adsorption by one of the quartz species (L or D) could have led to the homochirality of biomolecules. Asymmetric adsorption at enantiomor-phic quartz crystals has been detected L-quartz preferentially adsorbs L-alanine. Asymmetrical hydrogenation using d- or L-quartz as active catalysts is also possible. However, if the information in a large number of publications is averaged out, as Klabunovskii and Thiemann could show, there is no clear preference in nature for one of the two enantiomorphic quartz structures. It is possible that rhomobohedral... 

Using Ir/MeO-Biphep/l2 catalyst system, a variety of substituted quinoline derivatives were hydrogenated in 95% yield and up to 96% ee. This method provided an efficient accesss to three naturally occurring alkaloids (Scheme 17).328 Ferrocene N, P ligand 108 is also effective for the asymmetric hydrogenation of quinolines with up to 92% ee.188a... 

The broad range of alkenes undergoing asymmetric hydrogenation using ruthenium-based systems as catalysts has attracted the attention of chemists engaged in the synthesis of chiral biologically active natural products (Scheme 13)[60] and other pharmaceuticals (Scheme 14)[61]. a, (3-Unsaturated phosphoric acids and esters have also proved to be suitable substrates for Ru(II)-catalysed asymmetric hydrogenation [62]. 

The enantioselectivity is not very sensitive to the nature of the allylic alcohol. By contrast, titanium and tartrates are essential to the success. This catalyst components combination is unique note the difference with the L-Dopa asymmetric hydrogenation, which can be carried out with hundreds of C2-chiral diphosphines, even monophosphines, but with a limited number of substrates only. 

Since the discovery and development of highly efficient Rh catalysts with chiral diphosphites and phosphine-phosphites in the 1990s, the enantioselectivity of asymmetric hydroformylation has reached the equivalent level to that of asymmetric hydrogenation for several substrates. Nevertheless, there still exist substrates that require even further development of more efficient chiral ligands, catalyst systems, and reaction conditions. Diastereoselective hydroformylation is expected to find many applications in the total synthesis of complex natural products as well as the syntheses of biologically active compounds of medicinal and agrochemical interests in the near future. Advances in asymmetric hydrocarboxylation has been much slower than that of asymmetric hydroformylation in spite of its high potential in the syntheses of fine chemicals. 

The enantioselective hydrogenation of olefins, ketones and imines still represents an important topic and various highly enantioselective processes based on chiral Rh, Ru or Ir complexes have been reported. However, most of these catalysts failed to give satisfactory results in the asymmetric hydrogenation of aromatic and heteroaromatic compounds and examples of efficient catalysts are rare. This is especially the case for the partial reduction of quinoline derivatives which provide 1,2,3,4-tetrahydroquinolines, important synthetic intermediates in the preparation of pharmaceutical and agrochemical products. Additionally, many alkaloid natural products consist of this stmctural key element. 

When activated by metallic catalysts, hydrogen may be transferred from the metallic center to unsaturated organic molecules. The nature and reactivity of transition metal hydrides depend on the central metals as well as on the electronic and steric properties of the ligands. Metal hydrides with optically active ligands are chiral and thus, are capable of asymmetric hydrogenation. 

Heterogeneous asymmetric hydrogenation of 1,3-diketones is achieved by using a chirally modified Raney Ni catalyst (Scheme 1.51) [241]. Desired chiral diols are obtainable with about 90% ee. This method has been used for the synthesis of some naturally occurring compounds [242],... 

The insolubilized DIOP catalyst (34) was found to be rather ineffective for the asymmetric hydrogenation of oleflnic substrates the hydrogenation of a-ethyl-styrene proceeded readily but gave (-)-R-2-phenylbutane with an optical purity of only 1.5%. Methyl atropate was hydrogenated to (+)-S-methylhydratropate (2.5% ee). The soluble DIOP catalyst gave 15 and 17% ee, respectively, for the same reductions. The optical purity of the products was lower when recovered insolubilized catalyst was used. There was no reduction of a-acetamidocinnamic acid in ethanol-benzene with the insolubilized catalyst, presumably due to the hydrophobic nature of the polymer support causing it to shrink in hydroxylic solvents. 

---